Beutler B A
University of Texas Southwestern Medical Center at Dallas, Howard Hughes Medical Institute, 75235-9050, USA.
J Rheumatol Suppl. 1999 May;57:16-21.
The vast and growing array of cytokines is the subject of intense research for their potential to ameliorate a range of diseases that extends from autoimmune disorders to cancer and beyond. Among the cytokines, tumor necrosis factor-alpha (TNF-alpha) has proven to be a key ligand in triggering many intracellular processes, both physiological and pathological. Understanding its role in rheumatoid arthritis and Crohn's disease has produced effective new therapeutic agents, and there is reason to expect greater success as research proceeds. New synthetic macromolecules are effectively interfering with TNF and other ligands at and before the cellular membrane interface. This article reviews current knowledge of the molecular mechanics of TNF and the therapeutic inhibition of TNF action. Unraveling these processes has led to many insights into cytokine physiology and pathology.
数量众多且不断增加的细胞因子因其具有改善一系列疾病(从自身免疫性疾病到癌症及其他疾病)的潜力而成为深入研究的对象。在细胞因子中,肿瘤坏死因子-α(TNF-α)已被证明是触发许多生理和病理细胞内过程的关键配体。了解其在类风湿性关节炎和克罗恩病中的作用已产生了有效的新型治疗药物,并且随着研究的推进,有理由期待取得更大的成功。新型合成大分子正在细胞膜界面及之前有效地干扰TNF和其他配体。本文综述了关于TNF分子机制及TNF作用的治疗性抑制的当前知识。揭示这些过程已带来了许多关于细胞因子生理学和病理学的见解。